Abstract:N6-methyladenosine (m6A) is a dynamic posttranscriptional RNA modification that plays an important role in determining transcript fate. The functional consequence of m6A deposition is dictated by a group of host proteins that specifically recognize and bind the m6A modification, leading to changes in RNA stability, transport, splicing, or translation. The cellular m6A methylome undergoes changes during certain pathogenic conditions such as viral infections. However, how m6A modification of host cell transcripts and noncoding RNAs change during severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection has not been reported. Here, we define the epitranscriptomic m6A profile of SARS-CoV-2-infected human lung epithelial cells compared to uninfected controls. We identified mRNA and long and small noncoding RNA species that are differentially m6A modified in response to SARS-CoV-2 infection. The most significantly differentially methylated transcript was the precursor of microRNA-4486 (miRNA-4486), which showed significant increases in abundance and percentage of methylated transcripts in infected cells. Pathway analyses revealed that differentially methylated transcripts were significantly associated with several cancer-related pathways, protein processing in the endoplasmic reticulum, cell death, and proliferation. Upstream regulators predicted to be associated with the proteins encoded by differentially methylated mRNAs include several proteins involved in the type-I interferon response, inflammation, and cytokine signaling. IMPORTANCE Posttranscriptional modification of viral and cellular RNA by N6-methyladenosine (m6A) plays an important role in regulating the replication of many viruses and the cellular immune response to infection. We therefore sought to define the epitranscriptomic m6A profile of human lung epithelial cells infected with SARS-CoV-2. Our analyses demonstrate the differential methylation of both coding and noncoding cellular RNAs in SARS-CoV-2-infected cells compared to uninfected controls. Pathway analyses revealed that several of these RNAs may be involved in the cellular response to infection, such as type-I interferon. Our study implicates m6A modification of infected-cell RNA as a mechanism of posttranscriptional gene regulation during SARS-CoV-2 infection.

m6A methylation of transcription leader sequence impacts discontinuous transcription of subgenomic mRNAs

Methyltransferase-like 3 Modulates Severe Acute Respiratory Syndrome Coronavirus-2 RNA N6-Methyladenosine Modification and Replication

The m6A methylome of SARS-CoV-2 in host cells

Epitranscriptomic N6-Methyladenosine Profile of SARS-CoV-2-Infected Human Lung Epithelial Cells

METTL3 regulates viral m6A RNA modification and host cell innate immune responses during SARS-CoV-2 infection

Direct RNA Sequencing Reveals SARS-CoV-2 m6A Sites and Possible Differential DRACH Motif Methylation among Variants

Viral N6-methyladenosine Upregulates Replication and Pathogenesis of Human Respiratory Syncytial Virus.

Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells

Epitranscriptomic m5C methylation of SARS-CoV-2 RNA regulates viral replication and the virulence of progeny viruses in the new infection

m6A Regulates the Stability of Cellular Transcripts Required for Efficient KSHV Lytic Replication

METTL5, an 18S Rrna-Specific M6a Methyltransferase, Modulates Expression of Stress Response Genes

Viral and Host Transcriptomes in SARS-CoV-2-Infected Human Lung Cells

N6-methyladenosine RNA methylation modification regulates the transcription of viral-derived E (XSR) miRNAs to promote ALV-J replication

Identification of Aromatic Amino Acid Residues in Conserved Region VI of the Large Polymerase of Vesicular Stomatitis Virus is Essential for Both Guanine-N-7 and Ribose 2'-O Methyltransferases.

Dynamic control of chromatin-associated m6A methylation regulates nascent RNA synthesis

M6a Methylation: a Potential Key Player in Understanding and Treating COVID-2019 Infection

The epitranscriptome of Vero cells infected with SARS-CoV-2 assessed by direct RNA sequencing reveals m6A pattern changes and DRACH motif biases in viral and cellular RNAs

Despite the odds: formation of the SARS-CoV-2 methylation complex

Identification of SARS-CoV-2 m6A modification sites correlate with viral pathogenicity

N6-methyladenosine modification enables viral RNA to escape recognition by RNA sensor RIG-I

m6A modification controls the innate immune response to infection by targeting type I interferons